Solventum Future Growth
Future criteria checks 1/6
Solventum's earnings are forecast to decline at 15.6% per annum while its annual revenue is expected to grow at 0.2% per year. EPS is expected to decline by 20.1% per annum. Return on equity is forecast to be 21.5% in 3 years.
Key information
-15.6%
Earnings growth rate
-20.1%
EPS growth rate
Medical Equipment earnings growth | 16.9% |
Revenue growth rate | 0.2% |
Future return on equity | 21.5% |
Analyst coverage | Good |
Last updated | 15 Jul 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,311 | 878 | 1,048 | 1,505 | 4 |
12/31/2025 | 8,159 | 855 | 903 | 1,379 | 6 |
12/31/2024 | 8,105 | 898 | 770 | 1,203 | 5 |
3/31/2024 | 8,202 | 1,290 | 1,521 | 1,848 | N/A |
12/31/2023 | 8,197 | 1,346 | 1,625 | 1,915 | N/A |
9/30/2023 | 8,166 | 1,381 | 1,530 | 1,814 | N/A |
6/30/2023 | 8,101 | 1,256 | 1,542 | 1,817 | N/A |
3/31/2023 | 8,083 | 1,286 | 1,560 | 1,820 | N/A |
12/31/2022 | 8,130 | 1,343 | 1,428 | 1,679 | N/A |
12/31/2021 | 8,171 | 1,460 | 1,925 | 2,202 | N/A |
12/31/2020 | 7,281 | 1,138 | 1,755 | 2,026 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOLV's earnings are forecast to decline over the next 3 years (-15.6% per year).
Earnings vs Market: SOLV's earnings are forecast to decline over the next 3 years (-15.6% per year).
High Growth Earnings: SOLV's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SOLV's revenue (0.2% per year) is forecast to grow slower than the US market (8.6% per year).
High Growth Revenue: SOLV's revenue (0.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOLV's Return on Equity is forecast to be high in 3 years time (21.5%)